Periodic Reporting for period 3 - TIGER (Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine)

TIGER delivers proof of principle (PoP) in humans for a novel best-in-class mRNA cancer vaccine platform optimized for intravenous (IV) administration, with the aim to show major clinical efficacy. The antigens used for the PoP consists of mRNAs encoding the proteins E6 and E7...